Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Canil CM"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Stecca CE; Division of Hematology and Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada., Chowdhury D; Division of Hematology and Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada., Blais N; Division of Medical Oncology/Hematology, Centre Hospitalier de l' Université de Montréal, Montreal, QC, Canada., Alimohamed N; Department of Medicine, Division of Medical Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada., Wood L; Division of Medical Oncology, QEII Health Sciences Center, Halifax, NS, Canada., Canil CM; The Ottawa Hospital Cancer Center, Ottawa, ON Canada; Ottawa Hospital Research Institute, Ottawa, ON, Canada., Eigl B; BC Cancer, Vancouver, BC, Canada., Kulkarni GS; Divisions of Urology and Surgical Oncology, Department of Surgery, University Health Network, University of Toronto, Toronto, ON, Canada., Black PC; Department of Urological Sciences, University of British Columbia, Vancouver, BC, Canada., Kassouf W; Department of Surgery, McGill University Health Center, Montreal, QC, Canada., Chung P; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., North S; Department of Medical Oncology, Cross Cancer Institute, Edmonton, AB, Canada., Jiang DM; Division of Hematology and Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada., Sridhar SS; Division of Hematology and Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada., Bossé D, Breau RH, Conter H
Publikováno v:
Canadian Urological Association journal = Journal de l'Association des urologues du Canada [Can Urol Assoc J] 2024 Dec; Vol. 18 (12), pp. 379-390.
Autor:
Graham J; Department of Medical Oncology and Hematology, University of Manitoba, Winnipeg, MB, Canada., Ahmad AE; Division of Urology, Department of Surgery, University of Manitoba, Winnipeg, MB, Canada., Basappa NS; Department of Medical Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada., Bernhard JC; Department of Urology, CHU de Bordeaux, France., Bhindi B; Section of Urology, Department of Surgery, University of Calgary, Calgary, AB, Canada., Bossé D; The Ottawa Hospital Research Institute, Division of Medical Oncology, University of Ottawa, Ottawa, ON, Canada., Breau RH; The Ottawa Hospital Research Institute, Division of Urology, Department of Surgery, University of Ottawa, Ottawa, ON, Canada., Canil CM; The Ottawa Hospital Research Institute, Division of Medical Oncology, University of Ottawa, Ottawa, ON, Canada., Castonguay V; Chu de Québec, Université Laval, Quebec, QC, Canada., Finelli A; Division of Urology, Department of Surgery, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada., Heng DYC; Department of Oncology, Arthur JE Child Comprehensive Cancer Centre, University of Calgary, Calgary, AB, Canada., Inman BA; Division of Urology, Western University, London, ON, Canada., Kollmannsberger C; Department of Medical Oncology, BC Cancer-Vancouver Center, Vancouver, BC, Canada., Lalani AA; Department of Oncology, Juravinski Cancer Centre, McMaster University, Hamilton, ON, Canada., Lavallée LT; The Ottawa Hospital Research Institute, Division of Urology, Department of Surgery, University of Ottawa, Ottawa, ON, Canada., Msaouel P; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Prendeville S; Laboratory Medicine Program, University Health Network, Toronto, ON, Canada., Soleimani M; Department of Medicine, Medical Oncology Division, BC Cancer-Vancouver Centre, University of British Columbia, Vancouver, BC, Canada., Tanguay S; Division of Urology, McGill University Health Centre, Montreal, QC, Canada., Wood L; Division of Medical Oncology, Dalhousie University, Halifax, NS, Canada., Richard PO; Division of Urology, Centre Hospitalier Universitaire de Sherbrooke and Université de Sherbrooke Cancer Research Institute, Sherbrooke, QC, Canada., Alimohamed N, Huynh M, Kassouf W, Noonan K, Power N
Publikováno v:
Canadian Urological Association journal = Journal de l'Association des urologues du Canada [Can Urol Assoc J] 2024 Nov; Vol. 18 (11), pp. E371-E386.
Autor:
Lalani AA; Department of Medical Oncology, Juravinski Cancer Centre, McMaster, Hamilton, ON, Canada., Kapoor A; St Joseph's Healthcare Hamilton, McMaster University, Hamilton, ON, Canada., Basappa NS; Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada., Bhindi B; Southern Alberta Institute of Urology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada., Bjarnason GA; Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada., Bosse D; Division of Medical Oncology, University of Ottawa, Ottawa, ON, Canada., Breau RH; Department of Surgery, University of Ottawa, Ottawa, ON, Canada., Canil CM; Division of Medical Oncology, University of Ottawa, Ottawa, ON, Canada., Cardenas LM; Department of Medical Oncology, Juravinski Cancer Centre, McMaster, Hamilton, ON, Canada., Castonguay V; Centre de recherche du Centre Hospitalier Universitaire de Québec - Université Laval (CRCHUQc-UL), Centre de recherche sur le cancer (CRC) de l'Université Laval, Québec, QC, Canada., Chavez-Munoz C; Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada., Chu W; Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada., Dudani S; Department of Oncology, William Osler Health System, Brampton, ON, Canada., Graham J; University of Manitoba, Winnipeg, MB, Canada., Heng DYC; Department of Medical Oncology, Tom Baker Cancer Center, Calgary, AB, Canada., Kollmannsberger C; BC Cancer - Vancouver Centre, Vancouver, BC, Canada., Lattouf JB; Department of Surgery, University of Montreal, Montreal, QC, Canada., Morgan S; Department of Radiation Oncology, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada., Reaume MN; Division of Medical Oncology, University of Ottawa, Ottawa, ON, Canada., Richard PO; Department of Urology, Centre Hospitalier Universitaire de Sherbrooke and Centre de Recherche du CHUS, Sherbrooke, QC, Canada., Swaminath A; Department of Radiation Oncology, Juravinski Cancer Centre, McMaster University, Hamilton, ON, Canada., Tanguay S; Division of Urology, Department of Surgery, McGill University, Montreal, QC, Canada., Wood LA; Division of Medical Oncology, Dalhousie University, Halifax, NS, Canada., Lavallée LT; Division of Urology and Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.
Publikováno v:
Canadian Urological Association journal = Journal de l'Association des urologues du Canada [Can Urol Assoc J] 2023 May; Vol. 17 (5), pp. E154-E163.
Autor:
Donskov F; Aarhus University Hospital, Aarhus, Denmark. Electronic address: fd@oncology.au.dk., Xie W; Dana-Farber Cancer Institute, Boston, MA, USA., Overby A; Aarhus University Hospital, Aarhus, Denmark., Wells JC; Tom Baker Cancer Center, Calgary, Canada., Fraccon AP; Medical Oncology Unit, Ospedale Pederzoli, Peschiera del Garda, Verona, Italy., Sacco CS; Medical Oncology Unit, Ospedale Pederzoli, Peschiera del Garda, Verona, Italy., Porta C; IRCCS San Matteo University Hospital, Pavia, Italy., Stukalin I; Tom Baker Cancer Center, Calgary, Canada., Lee JL; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Koutsoukos K; Nation and Kapodistrian University of Athens, Athens, Greece., Yuasa T; Cancer Institute Hospital, Tokyo, Japan., Davis ID; Monash University and Eastern Health, Melbourne, Australia., Pezaro C; Monash University and Eastern Health, Melbourne, Australia., Kanesvaran R; National Cancer Centre Singapore, Singapore., Bjarnason GA; Sonnybrook Odette Cancer Center, Toronto, Canada., Sim HW; Princess Margaret Cancer Centre, Toronto, Canada., Rathi N; Huntsman Cancer Institute, Salt Lake City, UT, USA., Kollmannsberger CK; British Columbia Cancer Agency, Vancouver, Canada., Canil CM; Ottawa Hospital Cancer Centre, Ottawa, Canada., Choueiri TK; Dana-Farber Cancer Institute, Boston, MA, USA., Heng DYC; Tom Baker Cancer Center, Calgary, Canada.
Publikováno v:
European urology oncology [Eur Urol Oncol] 2020 Aug; Vol. 3 (4), pp. 530-539. Date of Electronic Publication: 2020 Feb 06.
Autor:
Warren M; Department of Medical Oncology, Cross Cancer Institute, Edmonton, AB, Canada.; Cancer Center, Bendigo Health, Bendigo, Australia., Kolinsky M; Department of Medical Oncology, Cross Cancer Institute, Edmonton, AB, Canada.; University of Alberta, Edmonton, AB, Canada., Canil CM; The Ottawa Hospital Cancer Center, Ottawa, ON Canada.; Ottawa Hospital Research Institute, Ottawa, ON, Canada., Czaykowski P; Cancer Care Manitoba, Winnipeg, MB, Canada.; University of Manitoba, Winnipeg, MB, Canada., Sridhar SS; Division of Hematology and Medical Oncology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, ON, Canada., Black PC; Department of Urological Sciences, University of British Columbia, Vancouver, BC, Canada., Booth CM; Department of Oncology, Queen's University, Kingston, ON, Canada., Kassouf W; Department of Surgery, McGill University Health Center, Montreal, QC, Canada., Eapen L; Division of Radiation Oncology, University of Ottawa, ON, Canada.; Ottawa Hospital Research Institute, Ottawa, ON, Canada., Mukherjee SD; Juravinski Cancer Center, Hamilton, ON, Canada., Blais N; Division of Medical Oncology/Hematology, Centre Hospitalier de l' Université de Montréal, Montreal, Quebec, Canada., Eigl BJ; BC Cancer, Vancouver, BC, Canada, University of British Columbia, BC, Canada., Winquist E; Division of Medical Oncology, Western University and London Health Sciences Center, London, ON, Canada., Basappa NS; Department of Medical Oncology, Cross Cancer Institute, Edmonton, AB, Canada.; University of Alberta, Edmonton, AB, Canada., North SA; Department of Medical Oncology, Cross Cancer Institute, Edmonton, AB, Canada.; University of Alberta, Edmonton, AB, Canada.
Publikováno v:
Canadian Urological Association journal = Journal de l'Association des urologues du Canada [Can Urol Assoc J] 2019 Oct; Vol. 13 (10), pp. 318-327.
Autor:
Bjarnason GA; Sunnybrook Odette Cancer Centre, 2075 Bayview Ave, Toronto, Ontario, M4N 3M5, Canada. Electronic address: georg.bjarnason@sunnybrook.ca., Knox JJ; Princess Margaret Cancer Centre, 610 University Avenue, Toronto, Ontario, M5G 2M9, Canada., Kollmannsberger CK; BC Cancer Agency, Vancouver Cancer Centre, Vancouver, British Columbia, V5Z 4E6, Canada., Soulieres D; Centre Hospitalier de L'Universite de Montreal, 1560 Sherbrooke Est, Montreal, Québec, H2L 4M1, Canada., Ernst DS; London Health Sciences Centre, 790 Commissioners Rd East, London, Ontario, N6A 4L6, Canada., Zalewski P; R.S. McLaughlin Durham Regional Cancer Centre, 1 Hospital Court, Oshawa, Ontario, L1G 2B9., Canil CM; The Ottawa Hospital Cancer Centre, 501 Smyth Road, Ontario, K1H 8L6, Canada., Winquist E; London Health Sciences Centre, 790 Commissioners Rd East, London, Ontario, N6A 4L6, Canada., Hotte SJ; Juravinski Cancer Centre, 699 Concession Street, Hamilton, Ontario, L8V 5C2, Canada., North SA; Cross Cancer Institute, 11560 University Avenue, Edmonton, Alberta, T6G 1Z2, Canada., Heng DYC; Tom Baker Cancer Center, 1331, 29th Avenue NW, Calgary, Alberta, Canada., Macfarlane RJ; Queen Elizabeth II Health Sciences Centre, 1276 South Park Street, Halifax, Nova Scotia, B3H 2Y9 Canada., Venner PM; Cross Cancer Institute, 11560 University Avenue, Edmonton, Alberta, T6G 1Z2, Canada., Kapoor A; Juravinski Cancer Centre, 699 Concession Street, Hamilton, Ontario, L8V 5C2, Canada., Hansen AR; Princess Margaret Cancer Centre, 610 University Avenue, Toronto, Ontario, M5G 2M9, Canada., Eigl BJ; BC Cancer Agency, Vancouver Cancer Centre, Vancouver, British Columbia, V5Z 4E6, Canada., Czaykowski P; Cancer Care Manitoba, 675 McDermot Avenue, Winnipeg, Manitoba, R3E 0V9, Canada., Boyd B; Ozmosis Research Inc, 65 Queen St W, Toronto, Ontario, M5H 2M5, Canada., Wang L; Princess Margaret Cancer Centre, 610 University Avenue, Toronto, Ontario, M5G 2M9, Canada., Basappa NS; Cross Cancer Institute, 11560 University Avenue, Edmonton, Alberta, T6G 1Z2, Canada.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2019 Feb; Vol. 108, pp. 69-77. Date of Electronic Publication: 2019 Jan 14.